High-risk admission prior to transcatheter aortic valve implantation and subsequent outcomes

Back

ESC Professional Premium Access

High-risk admission prior to transcatheter aortic valve implantation and subsequent outcomes

Session: TAVI outcomes: from pre-hospitalisation through valve choice and platelet reactivity

Topic: Aortic Valve Intervention

Speaker: Doctor J. Strange (Copenhagen, DK)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Jarl Emanuel Strange

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

1 follower

6 more presentations in this session

Mid-term outcomes in aortic stenosis patients treated with contemporary balloon expandable and self-expanding valves; does valve size have an impact on outcome?

Speaker: Doctor V. Panoulas (Harefield, Uxbridge, GB)

Impact of platelet reactivity on subclinical valve thrombosis in patients treated with TAVR

Speaker: Doctor P. Jimenez-Quevedo (Madrid, ES)

High rates of high on-aspirin platelet reactivity in patients after transcatheter aortic valve implantation

Speaker: Doctor D. Hesselbarth (Freiburg, DE)

Impact of visceral adipose tissue on mortality in patients undergoing transcatheter aortic valve implantation

Speaker: Doctor A. Somaschini (Savona, IT)

Coronary angiography and intervention after transcatheter aortic valve implantation (TAVI): the nationwide SWEDEHEART registry

Speaker: Doctor K. Nilsson (Uppsala, SE)

Access the full session

TAVI outcomes: from pre-hospitalisation through valve choice and platelet reactivity

Speakers: Doctor J. Strange, Doctor V. Panoulas, Doctor P. Jimenez-Quevedo, Doctor D. Hesselbarth, Doctor A. Somaschini...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources